Skip to main content
Signal8

Baker David Charles

SEC insider (Form 3/4/5 filer). CIK 0001844060. Director at GRI Bio, Inc. (GRI). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 18, 2025. Located in LA JOLLA, CA.

Companies Baker David Charles has filed insider reports for

  • GRI Bio, Inc. (GRI): Director
Baker David Charles profile photo

Baker David Charles

CIK: 0001844060

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GRI Bio, Inc. logo
GRI

GRI Bio, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • GRI Bio, Inc. logo
    GRI

    GRI Bio, Inc.

    Sep 18, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    23.6K shares-
  • GRI Bio, Inc. logo
    GRI

    GRI Bio, Inc.

    Aug 26, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    6K shares-
  • GRI Bio, Inc. logo
    GRI

    GRI Bio, Inc.

    Aug 13, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    4.5K shares-
  • GRI Bio, Inc. logo
    GRI

    GRI Bio, Inc.

    Jan 23, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    30.3K shares at avg. $0.69-

1-4 of 4